Vertex and Eli Lilly are revolutionizing non-opioid pain management with NaV1.8 advancements. See why I'm bullish about LLY ...

Vertex Pharmaceuticals is the global leader in cystic fibrosis treatment -- and that’s set to continue thanks to the ...

Vertex Pharmaceuticals Inc. closed 14.97% short of its 52-week high of $519.88, which the company achieved on November 8th.

An entrepreneur rolled out his prototype solar-powered car, named INTI, after the Inca sun god. But will solar cars heat up ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Three Motley Fool contributors believe they've found no-brainer healthcare stocks to buy in June. (Amgen): One of the best ...

Eli Lilly has reached a deal to acquire SiteOne Therapeutics that would give it control of a non-opioid pain drug that would ...

Get Honey for FREE today ▸ <a href=" Honey finds coupons with one click. Thanks to Honey for sponsoring! Keyboard build ...

Infosys launches 200+ enterprise AI agents with Google Cloud, transforming workflows and driving efficiency across industries ...

Continue » This stock is Vertex Pharmaceuticals (NASDAQ: VRTX), a biotech that's delivered a long track record of growth and profitability thanks to its leadership in the cystic fibrosis (CF ...

Wu draws more small donations from city residents while Kraft attracts larger contributions and significant out-of-state ...